{
    "Trade/Device Name(s)": [
        "SYNCHRON Systems Benzodiazepine Reagent"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K051307",
    "Predicate Device Reference 510(k) Number(s)": [
        "K023048"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JXM"
    ],
    "Summary Letter Date": "June 13, 2005",
    "Summary Letter Received Date": "May 19, 2005",
    "Submission Date": "May 18, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.3170"
    ],
    "Regulation Name(s)": [
        "Benzodiazepine test system"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "Benzodiazepines"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SYNCHRON CX4",
        "SYNCHRON CX4CE",
        "SYNCHRON CX4N4PRO",
        "SYNCHRON CX5",
        "SYNCHRON CX5CE",
        "SYNCHRON CX5\u2206",
        "SYNCHRON CX5PRO",
        "SYNCHRON CX7",
        "SYNCHRON CX7RTS",
        "SYNCHRON CX7N7PRO",
        "SYNCHRON CX9ALX",
        "SYNCHRON CX9PRO",
        "SYNCHRON LX20",
        "SYNCHRON LX20PRO",
        "UniCel DxC 600",
        "UniCel DxC 800"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoassay"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for SYNCHRON Systems Benzodiazepine Reagent immunoassay for qualitative detection of benzodiazepines in urine.",
    "Indications for Use Summary": "Qualitative determination of benzodiazepines in human urine at a cutoff value of 200 ng/mL (oxazepam) on SYNCHRON Systems; provides rapid screening for benzodiazepines, preliminary results require confirmatory testing.",
    "fda_folder": "Toxicology"
}